INVEGA TRINZA is a Intramuscular Injection, Suspension, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc. The primary component is Paliperidone Palmitate.
| Product ID | 50458-609_1ef256dc-8107-11eb-98e1-81dffb2ca371 |
| NDC | 50458-609 |
| Product Type | Human Prescription Drug |
| Proprietary Name | INVEGA TRINZA |
| Generic Name | Paliperidone Palmitate |
| Dosage Form | Injection, Suspension, Extended Release |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 2015-05-19 |
| Marketing Category | NDA / NDA |
| Application Number | NDA207946 |
| Labeler Name | Janssen Pharmaceuticals, Inc |
| Substance Name | PALIPERIDONE PALMITATE |
| Active Ingredient Strength | 819 mg/2.625mL |
| Pharm Classes | Atypical Antipsychotic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2015-05-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA207946 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2015-05-19 |
| Ingredient | Strength |
|---|---|
| PALIPERIDONE PALMITATE | 819 mg/2.625mL |
| SPL SET ID: | c39e65d7-fa44-4e4c-8b12-a654d3ed0eae |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50458-606 | INVEGA TRINZA | paliperidone palmitate |
| 50458-607 | INVEGA TRINZA | paliperidone palmitate |
| 50458-608 | INVEGA TRINZA | paliperidone palmitate |
| 50458-609 | INVEGA TRINZA | INVEGA TRINZA |
| 50458-560 | INVEGA SUSTENNA | paliperidone palmitate |
| 50458-561 | INVEGA SUSTENNA | paliperidone palmitate |
| 50458-562 | INVEGA SUSTENNA | paliperidone palmitate |
| 50458-563 | INVEGA SUSTENNA | paliperidone palmitate |
| 50458-564 | INVEGA SUSTENNA | paliperidone palmitate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() INVEGA TRINZA 86500977 4838342 Live/Registered |
JOHNSON & JOHNSON 2015-01-12 |